SI-BONE, Inc. (SIBN)
USD 13.25
(-2.57%)
USD 13.25
(-2.57%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 230.42 Million USD | 46.25% |
| 2022 | 157.55 Million USD | -17.3% |
| 2021 | 190.5 Million USD | -14.63% |
| 2020 | 223.14 Million USD | 90.7% |
| 2019 | 117 Million USD | -15.53% |
| 2018 | 138.52 Million USD | 286.56% |
| 2017 | 35.83 Million USD | -9.13% |
| 2016 | 39.43 Million USD | 9.38% |
| 2015 | 36.05 Million USD | 24.39% |
| 2014 | 28.98 Million USD | 60.9% |
| 2013 | 18.01 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 223.71 Million USD | -2.91% |
| 2024 Q2 | 223.84 Million USD | 0.06% |
| 2023 Q1 | 149.07 Million USD | -5.38% |
| 2023 Q4 | 230.42 Million USD | -0.2% |
| 2023 Q3 | 230.87 Million USD | -1.26% |
| 2023 FY | 230.42 Million USD | 46.25% |
| 2023 Q2 | 233.82 Million USD | 56.85% |
| 2022 Q4 | 157.55 Million USD | -0.45% |
| 2022 Q3 | 158.26 Million USD | -4.74% |
| 2022 Q2 | 166.14 Million USD | -6.05% |
| 2022 FY | 157.55 Million USD | -17.3% |
| 2022 Q1 | 176.84 Million USD | -7.17% |
| 2021 Q4 | 190.5 Million USD | -1.78% |
| 2021 Q3 | 193.96 Million USD | -6.45% |
| 2021 Q2 | 207.33 Million USD | -3.91% |
| 2021 Q1 | 215.76 Million USD | -3.31% |
| 2021 FY | 190.5 Million USD | -14.63% |
| 2020 FY | 223.14 Million USD | 90.7% |
| 2020 Q3 | 154.31 Million USD | -3.1% |
| 2020 Q2 | 159.24 Million USD | -5.11% |
| 2020 Q1 | 167.81 Million USD | 43.42% |
| 2020 Q4 | 223.14 Million USD | 44.6% |
| 2019 Q4 | 117 Million USD | -3.55% |
| 2019 FY | 117 Million USD | -15.53% |
| 2019 Q2 | 127.12 Million USD | -3.73% |
| 2019 Q3 | 121.31 Million USD | -4.57% |
| 2019 Q1 | 132.05 Million USD | -4.67% |
| 2018 Q2 | 29.91 Million USD | 0.0% |
| 2018 Q3 | 28.39 Million USD | -5.07% |
| 2018 Q4 | 138.52 Million USD | 387.84% |
| 2018 FY | 138.52 Million USD | 286.56% |
| 2018 Q1 | - USD | -100.0% |
| 2017 Q4 | 35.83 Million USD | 0.0% |
| 2017 Q1 | 40.98 Million USD | 0.0% |
| 2017 Q2 | - USD | -100.0% |
| 2017 FY | 35.83 Million USD | -9.13% |
| 2016 Q1 | - USD | 0.0% |
| 2016 FY | 39.43 Million USD | 9.38% |
| 2015 Q1 | 22.25 Million USD | -23.24% |
| 2015 FY | 36.05 Million USD | 24.39% |
| 2014 Q4 | 28.98 Million USD | 0.0% |
| 2014 FY | 28.98 Million USD | 60.9% |
| 2013 FY | 18.01 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -634.633% |
| BrainsWay Ltd. | 62.97 Million USD | -265.917% |
| Cerus Corporation | 197.74 Million USD | -16.525% |
| Envoy Medical, Inc. | 7.64 Million USD | -2916.034% |
| electroCore, Inc. | 16.38 Million USD | -1306.145% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -2895.645% |
| IceCure Medical Ltd | 16.41 Million USD | -1304.174% |
| Inogen, Inc. | 326.19 Million USD | 29.36% |
| OrthoPediatrics Corp. | 449.58 Million USD | 48.747% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -744.976% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -1289.86% |
| MaxCyte, Inc. | 268.27 Million USD | 14.108% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -2745.697% |
| Nexalin Technology, Inc. | 3.63 Million USD | -6244.447% |
| Orthofix Medical Inc. | 925.31 Million USD | 75.098% |
| PAVmed Inc | 33.11 Million USD | -595.749% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | -60.629% |
| RxSight, Inc. | 182.55 Million USD | -26.226% |
| Sight Sciences, Inc. | 166.65 Million USD | -38.268% |
| TELA Bio, Inc. | 78.04 Million USD | -195.235% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 8.528% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -2047.484% |
| Acutus Medical, Inc. | 53.96 Million USD | -327.029% |
| Talis Biomedical Corporation | 98.34 Million USD | -134.315% |
| Spectral AI, Inc. | 10.69 Million USD | -2055.116% |
| Nano-X Imaging Ltd. | 218.64 Million USD | -5.386% |
| CVRx, Inc. | 115.22 Million USD | -99.971% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | -292.808% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -7296.671% |
| Bioventus Inc. | 810.91 Million USD | 71.584% |
| Venus Concept Inc. | 93.65 Million USD | -146.039% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -795.724% |
| LivaNova PLC | 2.42 Billion USD | 90.516% |
| 908 Devices Inc. | 202.98 Million USD | -13.52% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 71.383% |
| Nemaura Medical Inc. | 14.56 Million USD | -1482.238% |
| NeuroPace, Inc. | 107.65 Million USD | -114.048% |
| LENSAR, Inc. | 69.58 Million USD | -231.142% |
| Apyx Medical Corporation | 79.24 Million USD | -190.794% |
| Cutera, Inc. | 346.29 Million USD | 33.459% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -448.422% |
| BioSig Technologies, Inc. | 1.79 Million USD | -12715.628% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 14.857% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | -440.13% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 93.907% |
| Axonics, Inc. | 719.92 Million USD | 67.993% |
| Outset Medical, Inc. | 313.8 Million USD | 26.57% |
| IRIDEX Corporation | 34.43 Million USD | -569.14% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 43.065% |
| IRadimed Corporation | 92.15 Million USD | -150.038% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -4285.706% |
| INVO Bioscience, Inc. | 20.88 Million USD | -1003.157% |
| Telesis Bio, Inc. | 70.41 Million USD | -227.257% |
| Viemed Healthcare, Inc. | 154.1 Million USD | -49.527% |
| Varex Imaging Corporation | 1.24 Billion USD | 81.56% |
| Quipt Home Medical Corp. | 247.4 Million USD | 6.864% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -2375.027% |
| Pulmonx Corporation | 178.95 Million USD | -28.764% |
| Dynatronics Corporation | 25.94 Million USD | -788.281% |
| Modular Medical, Inc. | 13.8 Million USD | -1568.9% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -2048.084% |
| Semler Scientific, Inc. | 78.06 Million USD | -195.171% |
| InMode Ltd. | 863.28 Million USD | 73.308% |
| Bruker Corporation | 4.24 Billion USD | 94.578% |
| Cytosorbents Corporation | 53.26 Million USD | -332.637% |
| DexCom, Inc. | 6.26 Billion USD | 96.322% |
| Align Technology, Inc. | 6.08 Billion USD | 96.213% |
| Viveve Medical, Inc. | 25.91 Million USD | -789.225% |
| ZimVie Inc. | 1.2 Billion USD | 80.883% |
| Movano Inc. | 9.42 Million USD | -2345.866% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 53.699% |
| Nexalin Technology, Inc. | 3.63 Million USD | -6244.447% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | -292.808% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 75.812% |
| Profound Medical Corp. | 43.68 Million USD | -427.453% |
| Insulet Corporation | 2.58 Billion USD | 91.097% |
| enVVeno Medical Corporation | 48.63 Million USD | -373.784% |
| Surmodics, Inc. | 185.73 Million USD | -24.062% |
| iCAD, Inc. | 41.41 Million USD | -456.34% |
| Nuwellis, Inc. | 9.77 Million USD | -2258.495% |
| Biotricity, Inc. | 5.94 Million USD | -3777.495% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 46.802% |
| Aethlon Medical, Inc. | 8.24 Million USD | -2694.391% |
| InspireMD, Inc. | 47.64 Million USD | -383.649% |
| PAVmed Inc. | 33.11 Million USD | -595.749% |
| BIOLASE, Inc. | 35.1 Million USD | -556.463% |
| Beyond Air, Inc. | 56.96 Million USD | -304.531% |
| FONAR Corporation | 214.24 Million USD | -7.552% |
| AxoGen, Inc. | 196.82 Million USD | -17.07% |
| Vivani Medical, Inc. | 45.79 Million USD | -403.144% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 18.126% |
| Inari Medical, Inc. | 674.23 Million USD | 65.824% |
| UFP Technologies, Inc. | 404.13 Million USD | 42.983% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -884.783% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -2324.732% |
| Tenon Medical, Inc. | 6.34 Million USD | -3531.6% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -2349.506% |
| Co-Diagnostics, Inc. | 103.64 Million USD | -122.316% |
| AdaptHealth Corp. | 4.61 Billion USD | 95.012% |
| Sintx Technologies, Inc. | 15.36 Million USD | -1399.675% |
| NanoVibronix, Inc. | 6.67 Million USD | -3352.577% |
| Quanterix Corporation | 425.01 Million USD | 45.784% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -2375.027% |
| Sensus Healthcare, Inc. | 53.72 Million USD | -328.881% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 86.803% |
| TransMedics Group, Inc. | 706.04 Million USD | 67.364% |
| ReWalk Robotics Ltd. | 63.19 Million USD | -264.643% |
| NeuroMetrix, Inc. | 21.42 Million USD | -975.524% |
| Hyperfine, Inc. | 94.19 Million USD | -144.615% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 14.226% |
| Biomerica, Inc. | 9.25 Million USD | -2390.004% |
| Bone Biologics Corporation | 3.73 Million USD | -6064.784% |
| AVITA Medical, Inc. | 144.33 Million USD | -59.64% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -4632.947% |
| Silk Road Medical, Inc | 265.3 Million USD | 13.148% |